Center for Medicinal Cannabis Research (CMCR @ UCSD)
LightNews LightNews
banner
cmcr-ucsd.bsky.social
Center for Medicinal Cannabis Research (CMCR @ UCSD)
@cmcr-ucsd.bsky.social
73 followers 36 following 210 posts
Established in 2000, the Center for Medicinal Cannabis Research at UCSD I has been at the forefront of advancing science and policy relating to the potential clinical benefits, and limitations, of cannabis and cannabinoids as medicine. www.cmcr.ucsd.edu.
Posts Replies Media Videos
cmcr-ucsd.bsky.social
📣 Participate in a study examining the impact of using high-THC cannabis dispensary products on driving ability 

Call or e-mail a representative!
(619) 543-5000
[email protected]
For more info: https://f.mtr.cool/kjgambqfur

#CannabisResearch #DrivingSafety #CannabisImpairedDriving
February 8, 2026 at 11:17 PM
cmcr-ucsd.bsky.social
📢 New Research | Cannabis & Driving
Dr. Tom Marcotte, PhD, and CMCR colleagues are featured in a UCSD Today article on the MADDI study, using a mobile lab to assess driving, attention, and memory before and after high-THC vaping or dabbing in real-world settings.
#CannabisResearch
February 7, 2026 at 7:59 PM
cmcr-ucsd.bsky.social
📢 New Phase 3 trial: Cannabis extract and low back pain relief🔬
A full-spectrum cannabis extract significantly reduced pain and improved sleep & function in adults with chronic low back pain vs placebo. 🌿💊
🔗 https://f.mtr.cool/kgjqivgxzg
#CannabisResearch
February 6, 2026 at 11:58 PM
cmcr-ucsd.bsky.social
🔬📢 New randomized, double-blind crossover pilot study
Acute CBD (150 mg) had no effect on VO2peak or time to exhaustion in recreationally active adults, suggesting no aerobic performance benefit or harm. 🏃‍♂️🌿
🔗 https://f.mtr.cool/uqvieqrggh
#CannabisResearch
February 5, 2026 at 10:47 PM
cmcr-ucsd.bsky.social
📢 CMCR 2026 RFA Released! We are actively funding studies on cannabis efficacy & adverse effects for medical/psychiatric disorders.

🗓️ LOI Due: Mar 6, 5pm PT 🗓️ App Due: Apr 24, 5pm PT

More info here: https://f.mtr.cool/oyqewnlrih

#CMCRGrantsProgram
February 4, 2026 at 11:08 PM
cmcr-ucsd.bsky.social
🔬📢 New alcohol–cannabis laboratory study
Cannabis use before drinking was linked to fewer drinks consumed and reduced alcohol craving in some heavy-drinking adults. Suggests substitution may occur for certain individuals. 🍺➡️🌿
🔗 https://f.mtr.cool/bneatqihwo
#CannabisResearch
February 3, 2026 at 10:42 PM
cmcr-ucsd.bsky.social
🌿 Did you miss the January CMCR Investigators’ Meeting? 🎙️ No worries—you can now watch Dr. Daniele Piomelli's presentation on Cannabinoids for the Treatment of Pain: The Case of Sickle-Cell Anemia🔬✨
🎥 Watch here → https://f.mtr.cool/tpkbdyelwa
#CannabisResearch #CMCR
February 2, 2026 at 11:44 PM
cmcr-ucsd.bsky.social
UCSD study on high-THC cannabis and driving ability.
Compensation up to $360.
https://f.mtr.cool/lxietakpwu
#CannabisResearch
February 1, 2026 at 11:17 PM
cmcr-ucsd.bsky.social
🔬📢 New longitudinal observational study
Adults initiating medical cannabis reported sustained improvements in subjective sleep quality over 12 months. Observational and self-reported data—controlled trials needed. 🔗 https://f.mtr.cool/kculiwitxo #CannabisResearch
January 31, 2026 at 10:33 PM
cmcr-ucsd.bsky.social
📢 CMCR 2026 RFA Released! We are actively funding studies on cannabis efficacy & adverse effects for medical/psychiatric disorders.

🗓️ LOI Due: Mar 6, 5pm PT 🗓️ App Due: Apr 24, 5pm PT

More info here: https://f.mtr.cool/ewtmuxhpvk

#CMCRGrantsProgram
January 30, 2026 at 11:08 PM
cmcr-ucsd.bsky.social
🔬📢 New systematic review and meta-analysis of animal studies
Cannabinoids improved outcomes in animal models of ischemic stroke, reducing infarct size, inflammation, and oxidative stress. Findings are preclinical and require human trials.
🔗 https://f.mtr.cool/cxbrpeoeyi
#CannabisResearch
Frontiers | Exploring the neuroprotective effects and underlying mechanisms of medical cannabinoids in ischemic stroke: a systematic meta-analysis with bibliometric mapping of cerebral ischemia research
BackgroundIschemic stroke is an acute neurological disorder with limited treatment options. Medical cannabinoids (MCs), primary bioactive compounds extracted...
f.mtr.cool
January 29, 2026 at 10:12 PM
cmcr-ucsd.bsky.social
UCSD study on high-THC cannabis and driving ability.
Compensation up to $360.
https://f.mtr.cool/lxietakpwu
#CannabisResearch
January 28, 2026 at 12:19 AM
cmcr-ucsd.bsky.social
📢 New research:
A randomized study of 23 fibromyalgia patients found THC reduced pain and improved offset analgesia. Baseline OA predicted pain relief, suggesting potential for personalized cannabinoid treatment.
https://f.mtr.cool/kywbtjzdoo
#CannabisResearch
January 28, 2026 at 12:19 AM
cmcr-ucsd.bsky.social
🌿 Did you miss the January CMCR Investigators’ Meeting? 🎙️ No worries—you can now watch Dr. Daniele Piomelli's presentation on Cannabinoids for the Treatment of Pain: The Case of Sickle-Cell Anemia🔬✨
🎥 Watch here → https://f.mtr.cool/evbkfqprxy
#CannabisResearch #CMCR
January 26, 2026 at 11:44 PM
cmcr-ucsd.bsky.social
📢 CMCR 2026 RFA Released! We are actively funding studies on cannabis efficacy & adverse effects for medical/psychiatric disorders.

🗓️ LOI Due: Mar 6, 5pm PT 🗓️ App Due: Apr 24, 5pm PT

More info here: https://f.mtr.cool/fdquueffxj

#CMCRGrantsProgram
January 23, 2026 at 11:08 PM
cmcr-ucsd.bsky.social
📆 Save the Date: Oct 1–2! The 2026 CMCR Symposium: Cannabis & Sport explores the science of performance & recovery. Virtual & Free! 🧠🏃‍♂️
Register: https://f.mtr.cool/urduwjecvz #CMCRSymposium
January 22, 2026 at 11:59 PM
cmcr-ucsd.bsky.social
📢 New Research
Vaporized cannabis flower for acute migraine: In a randomized crossover trial (N=92), THC+CBD improved pain relief, pain freedom, and symptom relief vs placebo. THC alone had limited benefit; CBD alone showed none.
🔗 https://f.mtr.cool/kpfoftafuy
#CannabisResearch
January 21, 2026 at 11:01 PM
cmcr-ucsd.bsky.social
📢 New Research 🌿🧠
In a randomized crossover trial, vaporized THC+CBD (6%/11%) improved acute migraine pain and symptoms at 2 h with sustained benefit to 24–48 h. THC alone helped pain; CBD alone did not.
🔗 https://f.mtr.cool/fhyuvbjkcd
#CannabisResearch
January 20, 2026 at 11:24 PM
cmcr-ucsd.bsky.social
📢 New Research 🧩
In a small RCT of autistic children, CBD did not improve overall social responsiveness but reduced anxiety, improved specific social behaviors, and lowered parental stress. Signals are symptom-specific and preliminary.
🔗 https://f.mtr.cool/zrzaofovjk
#CannabisResearch
January 20, 2026 at 12:16 AM
cmcr-ucsd.bsky.social
📢 New Study 🧠🏃
Among elite Canadian athletes, 38% reported CBD use—mainly for sleep, recovery, and pain—despite concerns about inadvertent anti-doping violations. Findings highlight the need for evidence-based guidance.
🔗 https://f.mtr.cool/epaledqdkt
#CannabisResearch
January 18, 2026 at 1:02 AM
cmcr-ucsd.bsky.social
📢 New Research 🩺
Updated review of 25 RCTs (n=2,303) finds high or comparable THC:CBD products offer small short-term pain relief—mainly neuropathic pain—with higher dizziness, sedation, and nausea. Benefits are modest; harms matter.
🔗 https://f.mtr.cool/pwoaxfwjee
#CannabisResearch
January 17, 2026 at 12:01 AM
cmcr-ucsd.bsky.social
📢 New Research 🧠
Dose–response links between adolescent cannabis use and poorer academic and emotional outcomes were observed—even among monthly users—in a national US sample (n=162,532). Cross-sectional but clinically relevant.
🔗 https://f.mtr.cool/ydfrjyxdnc
#CannabisResearch
January 15, 2026 at 8:46 PM
cmcr-ucsd.bsky.social
📢 New Study 💤
Adults (n=137) initiating medical cannabis reported significant, sustained improvements in sleep quality over 12 months. 📉 Improvement was seen regardless of administration route or referring condition.
🔗 https://f.mtr.cool/srzdsrthft
#CannabisResearch
January 14, 2026 at 12:15 AM
cmcr-ucsd.bsky.social
📢 New Research 🧠
In a randomized study of 23 fibromyalgia patients, THC reduced pain and improved Offset Analgesia (OA). Baseline OA predicted pain relief magnitude, suggesting OA may inform personalized cannabinoid treatment. 📉💊
https://f.mtr.cool/kywbtjzdoo
#CannabisResearch
January 13, 2026 at 8:40 PM
cmcr-ucsd.bsky.social
📢 New Research 🩺
A triple-blind RCT of 70 patients with primary hypertension found that 5 weeks of chronic CBD supplementation significantly reduced 24h blood pressure (~3-4 mmHg) compared to placebo. 📉❤️
Read more here: https://f.mtr.cool/yvolqrshox
#CannabisResearch
January 9, 2026 at 10:25 PM